PYRIDINE DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS

The present disclosure relates to a compound of the formula; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, and R6 are as defined herein. It also relates to pharmaceutical compositions comprising a compound of Formula I and to the use of the compound of Formula I for trea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KRUEGEL, Andrew Carry, O'NEILL, Brian Thomas, COE, Jotham Wadsworth
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KRUEGEL, Andrew Carry
O'NEILL, Brian Thomas
COE, Jotham Wadsworth
description The present disclosure relates to a compound of the formula; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, and R6 are as defined herein. It also relates to pharmaceutical compositions comprising a compound of Formula I and to the use of the compound of Formula I for treating psychiatric disorders. La présente invention concerne un composé de formule ; ou un sel pharmaceutiquement acceptable de celui-ci, R1, R2, R3, R4, R5 et R6 étant tels que définis dans la description. L'invention concerne également des compositions pharmaceutiques comprenant un composé de formule I et l'utilisation du composé de formule I pour traiter des troubles psychiatriques.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023205116A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023205116A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023205116A13</originalsourceid><addsrcrecordid>eNrjZDAPiAzydPH0c1VwcQ3yDHMM8QxzDVZw8w9SCAlyBfL83BUCgiOdPTwdQ4I8nRVcPIP9g4Aqg3kYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkbGRgamhoZmjoTFxqgAPtSl7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRIDINE DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS</title><source>esp@cenet</source><creator>KRUEGEL, Andrew Carry ; O'NEILL, Brian Thomas ; COE, Jotham Wadsworth</creator><creatorcontrib>KRUEGEL, Andrew Carry ; O'NEILL, Brian Thomas ; COE, Jotham Wadsworth</creatorcontrib><description>The present disclosure relates to a compound of the formula; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, and R6 are as defined herein. It also relates to pharmaceutical compositions comprising a compound of Formula I and to the use of the compound of Formula I for treating psychiatric disorders. La présente invention concerne un composé de formule ; ou un sel pharmaceutiquement acceptable de celui-ci, R1, R2, R3, R4, R5 et R6 étant tels que définis dans la description. L'invention concerne également des compositions pharmaceutiques comprenant un composé de formule I et l'utilisation du composé de formule I pour traiter des troubles psychiatriques.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231026&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023205116A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231026&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023205116A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KRUEGEL, Andrew Carry</creatorcontrib><creatorcontrib>O'NEILL, Brian Thomas</creatorcontrib><creatorcontrib>COE, Jotham Wadsworth</creatorcontrib><title>PYRIDINE DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS</title><description>The present disclosure relates to a compound of the formula; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, and R6 are as defined herein. It also relates to pharmaceutical compositions comprising a compound of Formula I and to the use of the compound of Formula I for treating psychiatric disorders. La présente invention concerne un composé de formule ; ou un sel pharmaceutiquement acceptable de celui-ci, R1, R2, R3, R4, R5 et R6 étant tels que définis dans la description. L'invention concerne également des compositions pharmaceutiques comprenant un composé de formule I et l'utilisation du composé de formule I pour traiter des troubles psychiatriques.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAPiAzydPH0c1VwcQ3yDHMM8QxzDVZw8w9SCAlyBfL83BUCgiOdPTwdQ4I8nRVcPIP9g4Aqg3kYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkbGRgamhoZmjoTFxqgAPtSl7</recordid><startdate>20231026</startdate><enddate>20231026</enddate><creator>KRUEGEL, Andrew Carry</creator><creator>O'NEILL, Brian Thomas</creator><creator>COE, Jotham Wadsworth</creator><scope>EVB</scope></search><sort><creationdate>20231026</creationdate><title>PYRIDINE DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS</title><author>KRUEGEL, Andrew Carry ; O'NEILL, Brian Thomas ; COE, Jotham Wadsworth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023205116A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KRUEGEL, Andrew Carry</creatorcontrib><creatorcontrib>O'NEILL, Brian Thomas</creatorcontrib><creatorcontrib>COE, Jotham Wadsworth</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KRUEGEL, Andrew Carry</au><au>O'NEILL, Brian Thomas</au><au>COE, Jotham Wadsworth</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRIDINE DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS</title><date>2023-10-26</date><risdate>2023</risdate><abstract>The present disclosure relates to a compound of the formula; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, and R6 are as defined herein. It also relates to pharmaceutical compositions comprising a compound of Formula I and to the use of the compound of Formula I for treating psychiatric disorders. La présente invention concerne un composé de formule ; ou un sel pharmaceutiquement acceptable de celui-ci, R1, R2, R3, R4, R5 et R6 étant tels que définis dans la description. L'invention concerne également des compositions pharmaceutiques comprenant un composé de formule I et l'utilisation du composé de formule I pour traiter des troubles psychiatriques.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2023205116A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PYRIDINE DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T04%3A02%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KRUEGEL,%20Andrew%20Carry&rft.date=2023-10-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023205116A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true